"For more than 50 years, we have built this practice around helping people see their best. That means providing the best specialists for each part of the eye and every type of vision problem. When you see a Sabates Eye Centers eye doctor, your care and treatment come from someone at the top of their field, along with technicians and staff who deliver true five-star service. All our physicians are involved in the teaching and research activities of the University of Missouri - Kansas City School of Medicine’s Department of Ophthalmology, Vision Research Center, Vision Research Foundation, and The Eye Foundation – all founded and managed by Dr. Felix Sabates and the Sabates Eye Centers team."

During the past decade, Eye Foundation of Kansas City conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eye Foundation of Kansas City" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Office of Dietary Supplements (ODS)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Eye Foundation of Kansas City" are "Macular Degeneration" (3 trials), "Age-related Macular Degeneration" (1 trials), "Cataract" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Eye Foundation of Kansas City" in a lesser frequency.

Most popular intervention types in "Eye Foundation of Kansas City" are "Drug" (5 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "pegaptanib sodium" (2 trials), "DHA/EPA" (1 trials), "Epi-Rad90™ Ophthalmic System" (1 trials), "Lutein/zeaxanthin" (1 trials) and "Lutein/zeaxanthin and DHA/EPA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eye Foundation of Kansas City" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Eye Foundation of Kansas City". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Eye Foundation of Kansas City, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Eye Foundation of Kansas City, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".